An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms

被引:57
|
作者
Maira-Litrán, T [1 ]
Allison, DG [1 ]
Gilbert, P [1 ]
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
D O I
10.1093/jac/45.6.789
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The chromosomal multiple antibiotic resistance operon, mar, is widely represented amongst Gram-negative bacteria and has been implicated in resistance towards oxidative stress agents, organic solvents and a large number of structurally unrelated antimicrobial agents. The major mechanism associated with such increased resistance is an upregulation of the efflux pump acrAB. Growth as a biofilm is often associated with similar generalized reductions in susceptibility to inimical agents. Escherichia coli K12 (AG100), an isogenic mutant of AG100 constitutive for mar expression (AG102) and an isolate deleted of the mar locus (MCH164) were grown as biofilms in cellulose-fibre depth filters and perfused with a simple salts, minimal medium (CDM) over 120 h. Biofilms were exposed to various concentrations of ciprofloxacin (0.004, 0.015 and 0.1 mg/L) for 42 h. The numbers of viable cells within the perfusate and within the biofilm were estimated throughout. Whereas no differences were seen between the wild-type and mar-deleted isolates, that constitutive for mar displayed reduced susceptibility to ciprofloxacin at concentrations of 0.004 mg/L (MIC for AG100 was 0.0052 mg/L). Similar antibiotic perfusion experiments were conducted using isolates in which the efflux pump acrAB was either deleted (AG100-A) or constitutively expressed (AG100-B). Exposure of AG100-A biofilms to ciprofloxacin at 0.004 and 0.1 mg/L showed similar susceptibilities to those seen in the wildtype (AG100) and mar-deleted (MCH164) isolates and suggested that acrAB was not induced within the attached population. On the other hand, constitutive expression of acrAB (AG100-B) protected biofilms against the lower concentration of ciprofloxacin used (0.004 mg/L). This protection was again lost at concentrations of 0.1 mg/L. Overall, these results show that ciprofloxacin resistance in biofilms is not mediated by the upregulation of the mar or acrAB operons.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 50 条
  • [1] AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants
    Okusu, H
    Ma, D
    Nikaido, H
    JOURNAL OF BACTERIOLOGY, 1996, 178 (01) : 306 - 308
  • [2] Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm
    Maira-Litrán, T
    Allison, DG
    Gilbert, P
    JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (02) : 243 - 247
  • [3] Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs
    White, DG
    Maneewannakul, K
    vonHofe, E
    Zillman, M
    Eisenberg, W
    Field, AK
    Levy, SB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) : 2699 - 2704
  • [4] CHARACTERIZATION OF MARR, THE REPRESSOR OF THE MULTIPLE ANTIBIOTIC-RESISTANCE (MAR) OPERON IN ESCHERICHIA-COLI
    SEOANE, AS
    LEVY, SB
    JOURNAL OF BACTERIOLOGY, 1995, 177 (12) : 3414 - 3419
  • [5] Expression of Multidrug Efflux Pump Genes acrAB-tolC, mdfA, and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug Resistance
    Swick, Michelle C.
    Morgan-Linnell, Sonia K.
    Carlson, Kimberly M.
    Zechiedrich, Lynn
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 921 - 924
  • [6] Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli
    Wan, Xiulin
    Li, Qingyang
    Olsen, Rikke Heidemann
    Meng, Hecheng
    Zhang, Zhigang
    Wang, Junlin
    Zheng, Hanyu
    Li, Lili
    Shi, Lei
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2158 - 2166
  • [7] Sodium Malonate Inhibits the AcrAB-TolC Multidrug Efflux Pump of Escherichia coli and Increases Antibiotic Efficacy
    Cauilan, Allea
    Ruiz, Cristian
    PATHOGENS, 2022, 11 (12):
  • [8] THIOLACTOMYCIN RESISTANCE IN ESCHERICHIA-COLI IS ASSOCIATED WITH THE MULTIDRUG-RESISTANCE EFFLUX PUMP ENCODED BY EMRAB
    FURUKAWA, H
    TSAY, JT
    JACKOWSKI, S
    TAKAMURA, Y
    ROCK, CO
    JOURNAL OF BACTERIOLOGY, 1993, 175 (12) : 3723 - 3729
  • [9] The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli
    Chollet, R
    Chevalier, J
    Bryskier, A
    Pagés, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3621 - 3624
  • [10] Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli
    Hansen, LH
    Johannesen, E
    Burmolle, M
    Sorensen, AH
    Sorensen, SJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3332 - 3337